# Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin

Study · id `cardio:ct-nct01062516` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01062516](<https://clinicaltrials.gov/study/NCT01062516>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01062516

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01062516. Randomized; quadruple masking; primary purpose diagnostic. Start 2010-01 (registry gives no type); primary completion 2010-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01062516, source copy `cardio:ctgov-nct01062516-2010-10-05`, retrieved 2026-10-31)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01062516, source copy `cardio:ctgov-nct01062516-2010-10-05`, retrieved 2026-10-31)
- Primary completion: 2010-09 (actual) (ClinicalTrials.gov record NCT01062516, source copy `cardio:ctgov-nct01062516-2010-10-05`, retrieved 2026-10-31)
- Completion: 2010-09 (actual) (ClinicalTrials.gov record NCT01062516, source copy `cardio:ctgov-nct01062516-2010-10-05`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01062516, source copy `cardio:ctgov-nct01062516-2010-10-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01062516-2010-10-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
- Condition: Acute Coronary Syndrome
- Condition: Acute Myocardial Infarction
- Intervention (Drug): esomeprazole 20 mg daily
- Intervention (Drug): famotidine 40 mg daily
- Lead sponsor: Ruttonjee Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial (`cardio:pubmed-22093203`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 125b1d87858303dd7ad8954c97ccf874e3f53face54f77717158598e3492b3c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
